New Perspectives on Treatment of Depression in Coronary Heart Disease

Robert M Carney1, Kenneth E Freedland

  • 1From the Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri.

PubMed

Insights

Major depression significantly increases cardiac event risk in coronary heart disease (CHD) patients. However, research on whether treating depression improves cardiac outcomes and survival remains inconclusive.

Area of Science:

  • Cardiology
  • Psychiatry
  • Psychosomatic Medicine

Background:

  • Major depression is a known risk factor for cardiac events and mortality in patients with coronary heart disease (CHD).
  • Previous studies, including landmark research from the 1980s and 1990s, established a link between depression and adverse cardiac outcomes.
  • Despite extensive research and clinical trials, the impact of depression treatment on medical outcomes in CHD patients remains unclear.

Purpose of the Study:

  • To explore the reasons behind the difficulty in determining the efficacy of depression treatment on cardiac survival in CHD patients.
  • To propose future research directions aimed at definitively assessing whether treating depression can improve cardiac event-free survival and quality of life.

Main Methods:

  • Review of existing literature on depression as a risk factor for cardiac events and mortality.
  • Analysis of clinical trials investigating the effects of depression treatment on CHD outcomes.
  • Identification of challenges and limitations in current research methodologies.

Main Results:

  • The precise impact of depression treatment on improving survival and reducing cardiac events in CHD patients is still not definitively established.
  • Existing studies and trials have yielded unclear results regarding the benefits of depression treatment in this population.

Conclusions:

  • Further research is needed to clarify the role of depression treatment in enhancing cardiac event-free survival and quality of life for CHD patients.
  • Developing robust research strategies is crucial to overcome current limitations and provide conclusive evidence.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
15
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
614
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
12
Depression: Overview01:18

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
294
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
Treatment Strategies for Psychological Disorders01:24

Treatment Strategies for Psychological Disorders

Treatment approaches for psychological disorders fall into three main categories: psychological, biological, and sociocultural. Each approach targets different aspects of mental health, requiring varying levels of education and training.
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
195